NAVAN Technologies

About:

NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies

Website: https://www.navanbio.com/

Twitter/X: Navan_Tech

Top Investors: National Science Foundation, HTGF | High-Tech Gruenderfonds, Amgen Ventures, Hemi Ventures

Description:

NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yet gentle and non-perturbative manne

Total Funding Amount:

$750000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)navan-tech.com

Founders:

Chris Rehse, Ryan Swoboda

Number of Employees:

11-50

Last Funding Date:

2019-04-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai